Methods: Study design: Cross-Sectional study. Setting: Medilink clinics, Karachi, Pakistan. Sample size and collection: 50 patients were included, indications and results of fibroscan patients were evaluated. Results: In our study of 50 patients, there were 39 (78%) males. Age ranged from 28–72 years. Mean age was 45.5 years. Indications include non-alcoholic fatty liver disease (NAFLD) 26 (52%) patients, chronic hepatitis 18 (36%) patients and 4 (8%) patients had history of chronic alcohol abuse, 1 patients was referred for assessment of liver fibrosis before chemotherapy and 1

patient had both chronic hepatitis and NAFLD. In 50 patients of fibroscan, 21 (42%) patients had significant fibrosis F3–F4. 09 patients had F-2 stage of fibrosis. 20 patients had F0 (no fibrosis) -F1 fibrosis. NAFLD was the most common indication and the results Selumetinib supplier from the 26 patients under that group were as follows, body mass index ranged from 26.6–33 ,12 (46.1%) patients had significant F3-F4 fibrosis, 5 (19.2%) patients had F-2 stage of fibrosis and 09 (34.6%) patients had F0-F1 stage

of fibrosis. Conclusion: Fibroscan now recognized as an acceptable alternative to liver biopsy, should be utilized more effectively in our population. In our study 21 out of 50 (42%) patients were found to have significant fibrosis which is helpful in MK-8669 planning further management of these patients. Key Word(s): 1. transient elastography; 2. liver fibrosis; 3. non-alcoholic fatty liver disease; 4. chronic viral hepatitis; Presenting Author: HENDRA KONCORO Additional Authors: KETUT MARIADI, GDE SOMAYANA, GUSTI AGUNG SURYADARMA, NYOMAN PURWADI, DEWA NYOMAN WIBAWA Corresponding Author: HENDRA KONCORO Affiliations: Department of Internal Medicine, Division of Gastroenterohepatology, Udayana University/Sanglah Hospital, Denpasar Objective: Findings of liver selleck screening library cirrhosis are usually accompanied with screening

endoscopy for large esophageal varices (EV) that may benefit from prophylactic measures. The aim of this study was to identify whether Model for End-stage Liver Disease (MELD) score, Child-Turcotte-Pugh (CTP) score, AST to platelet ratio index (APRI), FiB4 index, and laboratory tests could predict the presence of large EV among patients with liver cirrhosis in Sanglah Hospital Denpasar. Methods: A total of 90 hospitalized liver cirrhosis patients from September 2012 until March 2014 were restrospectively analyzed. Variables used in the analysis included age, sex, etiology of cirrhosis, CTP classification, MELD score, APRI, FiB4 index, platelet count, serum creatinine, and liver function tests. The presence of large EV was correlated with those characteristics.